US · Healthcare

Accustem Sciences Inc (ACUT)

Biotechnology

Accustem Sciences Inc (ACUT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ACUT

P/E ratio

25.00

Accustem Sciences Inc (ACUT) — FAQ

What is ACUT's P/E ratio?

The price-to-earnings (P/E) ratio for Accustem Sciences Inc (ACUT) is 25.00 (data as of 2026-05-23).

Does Accustem Sciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Accustem Sciences Inc (ACUT). Check the MyAverix Finance app for the latest dividend data.

What sector is Accustem Sciences Inc in?

Accustem Sciences Inc (ACUT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ACUT listed on?

ACUT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)